Answers are grounded in this paper and cite their sources.
A proteomics method to pull down secondary drug targets from live cells is described. The drug of interest is modified with trans-cyclooctene (TCO) and incubated with live cells. Upon cell lysis, the modified drug bound to the protein is pulled down using magnetic beads decorated with a cleavable tetrazine-modified linker. Samples are then run on an SDS-PAGE gel and isolated bands are submitted for mass spectrometry analysis to identify drug targets.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: